<DOC>
	<DOC>NCT02960828</DOC>
	<brief_summary>This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.</brief_summary>
	<brief_title>"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study</brief_title>
	<detailed_description>SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Retinal Drusen</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Drusen in both eyes examined under fundoscopy At least one of the eyes must have highrisk soft drusen BCVA below ETDRS 83 letters Patient with consent to participate Prior diagnosis with choroidal neovascularization Exudative AMD in at least one eye If the patient has only one visually effective eye (last eye) Other macula or retinal diseases than agerelated macular degeneration</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>